Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket)
- PMID: 31996596
- DOI: 10.1097/QAD.0000000000002446
Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket)
Similar articles
-
The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.Clin Infect Dis. 2015 Jun 1;60 Suppl 3(Suppl 3):S200-4. doi: 10.1093/cid/civ094. Clin Infect Dis. 2015. PMID: 25972505 Free PMC article.
-
HIV postexposure prophylaxis-in-pocket: long-term follow-up of individuals with low-frequency, high-risk HIV exposures.AIDS. 2020 Mar 1;34(3):433-437. doi: 10.1097/QAD.0000000000002441. AIDS. 2020. PMID: 31996594
-
Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV Exposures.J Acquir Immune Defic Syndr. 2018 May 1;78(1):20-22. doi: 10.1097/QAI.0000000000001639. J Acquir Immune Defic Syndr. 2018. PMID: 29419570
-
Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.Infect Dis Clin North Am. 2019 Sep;33(3):629-646. doi: 10.1016/j.idc.2019.04.002. Epub 2019 Jun 22. Infect Dis Clin North Am. 2019. PMID: 31239092 Review.
-
A Scoping Review of the Current Landscape of Pre-Exposure Prophylaxis and Postexposure Prophylaxis in India.AIDS Patient Care STDS. 2024 Jul;38(7):287-304. doi: 10.1089/apc.2024.0078. Epub 2024 May 27. AIDS Patient Care STDS. 2024. PMID: 38800957
Cited by
-
Validation of HIV Pre-Exposure Prophylaxis (PrEP) Medication Scales with Youth on PrEP: PrEP Confidence Scale and PrEP Difficulties Scale.AIDS Patient Care STDS. 2022 Nov;36(11):443-450. doi: 10.1089/apc.2022.0072. Epub 2022 Oct 27. AIDS Patient Care STDS. 2022. PMID: 36306520 Free PMC article. Clinical Trial.
-
Development and Validation of the Youth Pre-Exposure Prophylaxis (PrEP) Stigma Scale.AIDS Behav. 2023 Mar;27(3):929-938. doi: 10.1007/s10461-022-03829-9. Epub 2022 Aug 27. AIDS Behav. 2023. PMID: 36029425 Free PMC article.
-
Self-Reported Sexual Behavioral Similarities and Differences Among Young Men Who Have Sex With Men With Childhood Sexual Abuse Histories: A Qualitative Exploratory Study.Am J Mens Health. 2020 Jul-Aug;14(4):1557988320949355. doi: 10.1177/1557988320949355. Am J Mens Health. 2020. PMID: 32772691 Free PMC article.
References
-
- Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, et al. Preexposure prophylaxis for the prevention of HIV infection. Evidence report and systematic review for the US Preventive Services Task Force. JAMA 2019; 321:2214–2230.
-
- Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. ANRS IPERGAY Study Group. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med 2015; 373:2237–2246.
-
- Antoni G, Tremblay C, Charreau I, Cua E, Rojas-Castro D, Hall N, et al. On-demand PrEP with TDF/FTC remains highly effective among MSM with infrequent sexual intercourse: a sub-study of the ANRS IPERGAY trial. In: 9th International AIDS Society Conference, Paris, Abstract TUACO102, July 2017.
-
- Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline. Available at: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf. Published March 2018. (Accessed 5 November 2019)
-
- Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, et al. Antiretroviral drugs for treatment and prevention of HIV Infection in Adults: 2018 recommendations of the international antiviral society-USA panel. JAMA 2018; 320:379–396.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous